Structured Summary
Abstract
An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
3 entry terms
- Serotonin Syndromes
- Syndrome, Serotonin
- Syndromes, Serotonin
MeSH Record
Aspects Covered
35 allowable subheadings
Indexed with the subheadings blood, cerebrospinal fluid, chemically induced, classification, complications, congenital, diagnosis, diagnostic imaging, diet therapy, drug therapy, economics, embryology, enzymology, epidemiology, ethnology, etiology, genetics, history, immunology, metabolism, microbiology, mortality, nursing, parasitology, pathology, physiopathology, prevention & control, psychology, radiotherapy, rehabilitation, surgery, therapy, urine, veterinary, virology.
MeSH Record
History Note
1999
MeSH Record
Previous Indexing
- Serotonin (1980-1992)
- Serotonin Uptake Inhibitors/adverse effects (1993-1998)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Serotonin Syndrome. Medical Subject Headings (MeSH). 2026. Unique ID D020230. http://id.nlm.nih.gov/mesh/2026/D020230
- Serotonin Syndrome. In: Wikipedia. https://en.wikipedia.org/wiki/Serotonin_syndrome
- Serotonin Syndrome. In: Wikidata. https://www.wikidata.org/wiki/Q616181